About Vitro Master Diagnóstica
Vitro Master Diagnóstica is a Healthcare company based in Sevilla (Spain) founded in 2014, and was acquired by GED Capital in July 2017. Reagents for immunohistochemistry, molecular diagnostics, and instruments are developed. It operates on a Professional Services, Reseller / Distribution, and HealthTech model. Vitro Master Diagnóstica has completed 1 acquisition, including Cytognos. Its website vitro.bio draws about 12 thousand monthly visits. Vitro Master Diagnóstica offers products and services including Molecular Diagnostics, Anatomical Pathology, Reagents, Instrumentation, and Software. Its focus areas include Medical Devices and Diagnostic Equipment. Its legal entity is Vitro S.A.
Company details
Vitro Master Diagnóstica, operating as Vitro S.A., is engaged in the research, development, manufacturing, and commercialization of integrated diagnostic solutions. Focus is placed on oncological pathology and infectious diseases, with products including reagents, instrumentation, and software for molecular diagnostics and anatomical pathology. High-quality standards are maintained to support healthcare professionals in accurate diagnostics, while efforts are made to optimize integration into global healthcare systems. Personalized consulting services are offered by a team of qualified experts to meet client needs. Innovation and investment in research are prioritized to develop competitive products for the healthcare sector.
- Headquarters Sevilla, Spain
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vitro.bio
- Social LinkedIn
- Acquired by GED Capital (Jul 2017)
- Legal Name Vitro S.A.
- InvestorsBuenavista Equity Partners
& 1 more
- Investments & Acquisitions
- Acquired byGED Capital
(Jul 2017)
Products & Services of Vitro Master Diagnóstica
Vitro Master Diagnóstica offers a comprehensive portfolio of products and services, including Molecular Diagnostics, Anatomical Pathology, Reagents, Instrumentation, and Software.
Solutions for molecular diagnostics are developed and provided.
Comprehensive tools for anatomical pathology are designed meticulously.
Reagents for diagnostic testing are manufactured with precision.
Advanced instrumentation for diagnostics is created and supplied.
Software solutions for diagnostics are developed for efficiency.
Investors in Vitro Master Diagnóstica
Vitro Master Diagnóstica has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Buenavista Equity Partners and Headway Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Headway Capital Partners is engaged in private equity investments. | headwaycap.com | London, United Kingdom | ||
Buenavista Equity Partners is engaged in private equity investments. | 1996 | gedcapital.com | Madrid, Spain |
Investor details for Vitro Master Diagnóstica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vitro Master Diagnóstica
Vitro Master Diagnóstica has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cytognos.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Flow cytometry reagents, software, and solutions are developed. | cytognos.com | 1996 | Jul 2018 | •••• |
Complete acquisition details for Vitro Master Diagnóstica
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Vitro Master Diagnóstica
3 dated milestones of Vitro Master Diagnóstica across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Vitro Master Diagnóstica is founded.
- Exit Acquired by GED Capital.
- Acquisition Acquires Cytognos.
Web traffic of Vitro Master Diagnóstica
The website of Vitro Master Diagnóstica (vitro.bio) receives about 12.5K visits a month.
- Monthly visits12.5K
▲ 32.3% vs previous month
Websites whose visitors overlap most with Vitro Master Diagnóstica. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
aquimisa.com | aquimisa.com | 100% | #7,573,297 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vitro Master Diagnóstica
Vitro Master Diagnóstica was founded in 2014.
Vitro Master Diagnóstica is headquartered in Sevilla, Spain. It is registered at Sevilla, Andalucia, Spain.
Vitro Master Diagnóstica, operating as Vitro S.A., is engaged in the research, development, manufacturing, and commercialization of integrated diagnostic solutions. Focus is placed on oncological pathology and infectious diseases, with products including reagents, instrumentation, and software for molecular diagnostics and anatomical pathology. High-quality standards are maintained to support healthcare professionals in accurate diagnostics, while efforts are made to optimize integration into global healthcare systems. Personalized consulting services are offered by a team of qualified experts to meet client needs. Innovation and investment in research are prioritized to develop competitive products for the healthcare sector.
Vitro Master Diagnóstica offers Molecular Diagnostics, Anatomical Pathology, Reagents, Instrumentation, and Software.
Vitro Master Diagnóstica has made 1 acquisition, including Cytognos.
Vitro Master Diagnóstica has 2 investors. Key investors include Buenavista Equity Partners, and Headway Capital Partners.
Vitro Master Diagnóstica operates through Vitro S.A..
Yes. Vitro Master Diagnóstica was acquired by GED Capital in July 2017.